{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02975960",
      "OrgStudyIdInfo": {
        "OrgStudyId": "KC16TISI0343"
      },
      "Organization": {
        "OrgFullName": "The Catholic University of Korea",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "ADMSCs for the Treatment of Systemic Sclerosis",
      "OfficialTitle": "Adipose Tissue-derived Mesenchymal Stem Cells for Cell-based Therapy in the Treatment of Systemic Sclerosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2018",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 25, 2016",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 30, 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "January 20, 2018",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "November 9, 2016",
      "StudyFirstSubmitQCDate": "November 23, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 29, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "January 23, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 25, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Jung Hee Koh",
        "ResponsiblePartyInvestigatorTitle": "Clinical Professor, Principal Investigator",
        "ResponsiblePartyInvestigatorAffiliation": "The Catholic University of Korea"
      },
      "LeadSponsor": {
        "LeadSponsorName": "The Catholic University of Korea",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Seoul St. Mary's Hospital",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Systemic sclerosis (SSc) is a rare autoimmune disease, mainly characterized by cutaneous and visceral fibrosis. Digital ulcer and sclerosing skin are commonly affected on hands, but the treatment for these manifestations are often ineffective.\n\nAdipose tissue contains stromal vascular fraction (SVF), which is abundant multipotent stem cells, capable of tissue repair. A prior study (NCT01813279) has shown the safety and tolerance at 6 months of the subcutaneous injection of SVF in the fingers in SSc.\n\nThere are only few ways to manage SSc patients with skin lesion who already have treated with several medications (including vasodilators, PDE5 inhibitor, endothelin receptor antagonist) but some times their skin lesions are critical physically and emotionally.\n\nAutologous SVF injection could be one of the treatment options to treat skin lesion of SSc. Thus, the investigators study the efficacy and potential adverse event in Korean patients with SSc.",
      "DetailedDescription": "In this study, the investigators will inject autologous Stromal vascular fraction.\n\n1) Acquiring autologous stromal vascular fraction by plastic surgeon\n\nLiposuction\nExtraction and purifying SVF using Smart-X system (15-20 min)\nMaking syringe filled with autologous SVF\n\n2) SVF injection\n\nInject SVF subcutaneously with 25G needle in finger"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Systemic Sclerosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "systemic sclerosis",
          "adipose derived stem cell",
          "stromal vascular fraction",
          "digital ulcer",
          "gangrene"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "7",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Stromal vascular fraction injection",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Injection of autologous stromal vascular fraction on hand.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: injection of autologous stromal vascular fraction"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "injection of autologous stromal vascular fraction",
            "InterventionDescription": "Acquiring autologous stromal vascular fraction (SVF) from liposuction\npurifying SVF from lipoaspirates and making syringe filled with SVF\nSVF injection - Inject SVF on fingers subcutaneously.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Stromal vascular fraction injection"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Change from baseline modified Rodnan Skin score (mRSS) of hands at 12 weeks",
            "PrimaryOutcomeDescription": "Assess hands mRSS",
            "PrimaryOutcomeTimeFrame": "baseline, 12 weeks"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Change from baseline Raynaud's condition score at 12 weeks",
            "SecondaryOutcomeDescription": "The severity (frequency and intensity of crises) of Raynaud's phenomenon",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline Visual Analog Score for pain the hands at 12 weeks",
            "SecondaryOutcomeDescription": "Patient report hand pain degree, comparing baseline and 12 weeks",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Changes from baseline mRSS (total) at 12 weeks",
            "SecondaryOutcomeDescription": "Assess total mRSS (including hands)",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline Kapandji score at 12weeks",
            "SecondaryOutcomeDescription": "assess the mobility of both hands",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline Cochin hand function scale at 12 weeks",
            "SecondaryOutcomeDescription": "Assess hand function (patients reported outcome)",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline Systemic sclerosis HAQ at 12 weeks",
            "SecondaryOutcomeDescription": "he quality of life- score adapted to systemic sclerosis",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline peripheral vasculature at 12 weeks",
            "SecondaryOutcomeDescription": "Assess peripheral vascularity by Nailfold capillaroscopy",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline finger circumference at 12 weeks",
            "SecondaryOutcomeDescription": "Measure second to fifth finger circumference",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients who fulfill 2013 American college of Rheumatology/ European League Against Rheumatism Criteria for the classification of systemic sclerosis.\nThe skin lesion was not improved after 6 months treatment with conventional therapy.\n\nExclusion Criteria:\n\nPregnancy\nStart new medications within 3 months prior to enrollment\nPrevious sympathectomy or amputation\nCurrent systemic infection\nAIDS, Syphilis, hepatitis B&C\nBMI <17kg/m2\nCognitive dysfunction and other psychologic problems",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Jung Hee Koh, MD",
            "OverallOfficialAffiliation": "Seoul St.Mary's hospital, The Catholic university of Korea",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Seoul St. Mary's hospital",
            "LocationCity": "Seoul",
            "LocationZip": "06591",
            "LocationCountry": "Korea, Republic of"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012595",
            "ConditionMeshTerm": "Scleroderma, Systemic"
          },
          {
            "ConditionMeshId": "D000045743",
            "ConditionMeshTerm": "Scleroderma, Diffuse"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          },
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16358",
            "ConditionBrowseLeafName": "Ulcer",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14564",
            "ConditionBrowseLeafName": "Scleroderma, Systemic",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M24713",
            "ConditionBrowseLeafName": "Scleroderma, Diffuse",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8003",
            "ConditionBrowseLeafName": "Gangrene",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5565",
            "ConditionBrowseLeafName": "Systemic Scleroderma",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}